Beta Bionics, Inc. · NASDAQ:BBNX
Eventide Asset Management, LLC reported a 11.32% stake in Beta Bionics, Inc. (Schedule 13G)
Event Jan 31, 2025 · Filed Feb 5, 2025
Eventide Asset Management, LLC reported a 11.32% stake in Beta Bionics, Inc., 4,857,041 shares, as a passive investor on Jan 31, 2025. Filed Feb 5, 2025 (Schedule 13G).
- Stake
- 11.32%
- Shares
- 4,857,041
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Eventide Asset Management, LLC | 11.32% | 4,857,041 |
| Finny Kuruvilla, M.D., Ph. D. | 11.32% | 4,857,041 |
| Robin C. John | 11.32% | 4,857,041 |
Source
Related
- Beta Bionics, Inc.
- Eventide Asset Management, LLC
- Beta Bionics, Inc. shareholders
- Schedule 13G/A · Eventide Asset Management, LLC · May 15, 2026
- Form 4 · Hopman Mark · Oct 16, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Oct 7, 2026
- Form 4 · Hopman Mark · Oct 5, 2026
- Form 4 · Jones Christy · Sep 23, 2026
- Form 4/A · Hopman Mark · Sep 18, 2026